Answers are grounded in this paper and cite their sources.
Patients with squamous-cell carcinoma of the head and neck who received docetaxel plus cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy had a significantly longer survival than did patients who received cisplatin and fluorouracil induction chemotherapy plus chemoradiotherapy. (ClinicalTrials.gov number, NCT00273546 [ClinicalTrials.gov].).
No takes yet. Share an insight, caveat, or question.
Posner et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: